Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun).
about
Rapid-throughput skeletal phenotyping of 100 knockout mice identifies 9 new genes that determine bone strengthSelective genomic targeting by FRA-2/FOSL2 transcription factor: regulation of the Rgs4 gene is mediated by a variant activator protein 1 (AP-1) promoter sequence/CREB-binding protein (CBP) mechanismThe CCL2/CCR2 axis enhances vascular cell adhesion molecule-1 expression in human synovial fibroblastsAn RNA-seq protocol to identify mRNA expression changes in mouse diaphyseal bone: applications in mice with bone property altering Lrp5 mutationsA microRNA expression signature of osteoclastogenesisRegulation of c-Fos gene expression by NF-κB: a p65 homodimer binding site in mouse embryonic fibroblasts but not human HEK293 cellsLoss of transcription factor early growth response gene 1 results in impaired endochondral bone repair.Nmp4/CIZ suppresses the response of bone to anabolic parathyroid hormone by regulating both osteoblasts and osteoclasts.Immortalization and characterization of osteoblast cell lines generated from wild-type and Nmp4-null mouse bone marrow stromal cells using murine telomerase reverse transcriptase (mTERT).High-mobility group box-1 induces vascular remodelling processes via c-Jun activationArginine decreases peroxisome proliferator-activated receptor-γ activity via c-Jun.Chemokine Signaling Pathway Involved in CCL2 Expression in Patients with Rheumatoid Arthritis.Focal exposure of limited lung volumes to high-dose irradiation down-regulated organ development-related functions and up-regulated the immune response in mouse pulmonary tissues.Regulation of gene expression by tobacco product preparations in cultured human dermal fibroblastsGlobal transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency.Progression of chronic liver inflammation and fibrosis driven by activation of c-JUN signaling in Sirt6 mutant miceNmp4/CIZ closes the parathyroid hormone anabolic window.MicroRNA control of bone formation and homeostasis.MiR-142-3p is a RANKL-dependent inducer of cell death in osteoclasts.Thrombin promotes matrix metalloproteinase-13 expression through the PKCδ c-Src/EGFR/PI3K/Akt/AP-1 signaling pathway in human chondrocytes.Selective modulation of the glucocorticoid receptor can distinguish between transrepression of NF-κB and AP-1.Hall of Fame among Pro-inflammatory Cytokines: Interleukin-6 Gene and Its Transcriptional Regulation Mechanisms.Control of bone development by P2X and P2Y receptors expressed in mesenchymal and hematopoietic cells.LL202 protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting MAPK/AP-1 signaling.Baicalein reduces angiogenesis in the inflammatory microenvironment via inhibiting the expression of AP-1.Topical fluticasone propionate: intervention and maintenance treatment options of atopic dermatitis based on a high therapeutic index.Angiogenesis and vasculopathy in systemic sclerosis: evolving concepts.Redox regulation of inflammation: old elements, a new story.Identification of potential gene targets in systemic vasculitis using DNA microarray analysis.The Expression Level of mRNA, Protein, and DNA Methylation Status of FOSL2 of Uyghur in XinJiang in Type 2 Diabetes.Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion.Inhibition of Osteoarthritis by Adipose-Derived Stromal Cells Overexpressing Fra-1 in Mice.Estrogen modulates hepatic gene expression and survival of rainbow trout infected with pathogenic bacteria Yersinia ruckeri.Genome-wide association study of ulcerative colitis in Koreans suggests extensive overlapping of genetic susceptibility with Caucasians.Fra, Fra away: the complex role of activator protein 1 in liver injury.Liver X receptor activation inhibits osteoclastogenesis by suppressing NF-κB activity and c-Fos induction and prevents inflammatory bone loss in mice.Early growth response gene 1 regulates bone properties in mice.Activating transcription factor 2 targets c-Fos, but not c-Jun, in growth plate chondrocytes.Cell-cycle regulators cdk2ap1 and bicalutamide suppress malignant biological interactions between prostate cancer and bone cells.Thrombin induces epidermal growth factor receptor transactivation and CCL2 expression in human osteoblasts.
P2860
Q21563368-2B3DDF0C-CC5C-4CF3-BAAF-C67004AFBBD1Q28577552-83B54C12-F431-4930-A6D6-D10F7DC140AAQ34490864-02E2EF69-0413-43E2-A9C5-D4E7269A6D5BQ34647373-3D212975-8373-4267-812F-0147B714F859Q34774013-E5663214-7F55-4154-B0B9-2AA13141C5EAQ35080815-52815709-0794-4B75-A988-EF351C89F719Q35202895-A2031493-D32D-4AA9-9507-E4A62F167E7AQ35432065-144E5917-2121-46A3-A18C-94F28BBA2761Q35531974-6DC7BCCE-9C5A-459D-9658-09FACC05715DQ35571972-D70E995F-756A-4704-99FA-C3CB2ED438E2Q35722757-F8E823A2-930A-4FB9-BA65-88CBF4C225B0Q35778233-65D69667-480A-4639-B751-378C9F8974B3Q35906384-80EC9627-F74D-4738-8AEF-8146DC817109Q35956122-77A9EF7A-8F32-4F31-BAFD-C43F5D26C427Q36076501-8FEAF9A1-E76D-4919-A659-3C0537B8F2B9Q36451932-77262E16-CFA3-4A4F-B5CC-4DA5B6DBC104Q36650555-D5A3EC92-7513-4F32-A83D-C7DDEC2066BAQ36661323-D3F80A27-DE95-40BB-81AE-070D5F7F02C4Q36835508-336E0DE0-747F-47C0-93A6-AE8B203F09B9Q37412533-F12DCF1D-2B0D-46F8-B494-2FEC3064C13BQ37470723-5075549D-C267-4D05-BFBA-7E2F4A791C9BQ37512224-F36865E5-7643-4BEC-8C80-093C82025A58Q37608919-E59B5686-3E99-4BF2-B790-F671B51CA27AQ37665540-55AFA7A4-DA11-4D80-BE4E-599688B7830FQ37702378-59318931-2B08-4D64-82D9-880E52E00B39Q37942962-13441110-43FB-425F-8D25-5D2E9CE45A72Q37956146-62E778FF-E39C-4765-8F53-73812D98F6DFQ38244572-B30488FF-82AC-4EF1-9F41-40CB3887A3D2Q38821236-5A4DD770-3184-427F-B945-8EE8C7027855Q39041835-A7696A4C-F6CA-489F-AB7E-86E711C4281BQ39290041-3CC389A7-0CE1-4076-BC66-803EA46BF6EAQ40548887-19182F0C-7CA0-4254-A70C-430CDE4AF748Q41411335-2EDF28D9-5A60-4E2D-ABCF-2C78AA936573Q42692834-F04DB4A6-6D98-4766-A486-114B6AA68CE9Q45024723-0F520DB1-E402-4B2F-A901-507507B0492FQ46187570-CCDC959F-D56F-4244-8029-F2ED2EE029BBQ51469341-534BF589-4722-41F7-B043-9B0B5531B50DQ51553324-16247419-3C8C-4C54-BD14-AD8A79506A74Q53302883-1459101F-A26E-47DE-802B-89EBB9529FD2Q54306333-494E2D14-DD8C-4BDD-B729-AB0E2B637F55
P2860
Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun).
@en
Bone development and inflammatory disease is regulated by AP-1
@nl
type
label
Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun).
@en
Bone development and inflammatory disease is regulated by AP-1
@nl
prefLabel
Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun).
@en
Bone development and inflammatory disease is regulated by AP-1
@nl
P356
P1476
Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun)
@en
P2093
E F Wagner
P304
P356
10.1136/ARD.2009.119396
P407
P478
69 Suppl 1
P577
2010-01-01T00:00:00Z